Biogen (BIIB) stock soared to a 52-week high after exceeding Q2 expectations and BlackRock's $3.45B stake. Full-year outlook upgraded to growth mode. The post Biogen (BIIB) Stock Surges to 52-Week Peak After BlackRock’s $3.4B Investment appeared first on Blockonomi.